1-4 of 4
Donna Dorr
Close
Sort by
Journal Articles

Using Haploidentical (haplo) Donors and High-Dose Post-Transplant Cyclophosphamide (PTCy) for Refractory Severe Aplastic Anemia (SAA)

Amy E. DeZern, MD MHS, Donna Dorr, RN, MSN, AOCN, Leo Luznik, MD, Javier Bolanos-Meade, MD, Christopher Gamper, MD PhD, Heather J. Symons, MD MHS, Kenneth R. Cooke, MD, Richard J. Jones, Sr., MD, Robert A. Brodsky, MD
Journal: Blood
Blood (2015) 126 (23): 2031.
https://doi.org/10.1182/blood.V126.23.2031.2031
Published: 2015
Journal Articles

Predictors of Response to Eculizumab Therapy in Paroxysmal Nocturnal Hemoglobinuria.

Amy E. DeZern, MD, MHS, Donna Dorr, RN, MSN, AONC, Robert A. Brodsky, MD
Journal: Blood
Blood (2012) 120 (21): 2357.
https://doi.org/10.1182/blood.V120.21.2357.2357
Published: 2012
Journal Articles

High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up

Clinical Trials & Observations
Robert A. Brodsky, Allen R. Chen, Donna Dorr, Ephraim J. Fuchs, Carol Ann Huff, Leo Luznik, B. Douglas Smith, William H. Matsui, Steven N. Goodman, Richard F. Ambinder, Richard J. Jones
Journal: Blood
Blood (2010) 115 (11): 2136–2141.
https://doi.org/10.1182/blood-2009-06-225375
Published: 2010
Journal Articles

Modification of the Eculizumab Dose to Successfully Manage Intravascular Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria.

Richard Kelly, MD, Louise Arnold, BSc, MA, Stephen Richards, PhD, Anita Hill, MD, Sandra vanBijnen, MD, Petra Muus, MD, PhD, Donna Dorr, RN, MSN, AOCN, Robert Brodsky, MD, Gus Khursigara, PhD, Russell P. Rother, PhD, Peter Hillmen, MBChB, PhD
Journal: Blood
Blood (2008) 112 (11): 3441.
https://doi.org/10.1182/blood.V112.11.3441.3441
Published: 2008